Sarepta Archives -

Aduhelm approval could signal new era for CNS drugs; analysts

https://pharmaphorum.com/news/aduhelm-approval-could-signal-new-era-for-cns-drugs-analysts/

First UK patient joins Pfizer’s phase 3 DMD gene therapy trial

https://pharmaphorum.com/news/first-uk-patient-joins-pfizers-phase-3-dmd-gene-therapy-trial/

Gene Therapy for Muscular Disorders

https://pharmaphorum.com/events/gene-therapy-for-muscular-disorders/

Sarepta helps bankroll new gene therapy startup AavantiBio

https://pharmaphorum.com/news/sarepta-helps-bankroll-new-gene-therapy-startup-aavantibio/

NS Pharma takes on Sarepta as FDA approves DMD drug

https://pharmaphorum.com/news/ns-pharma-sarepta-fda-approves-dmd-drug/

Sarepta agree gene therapy R&D pact with Selecta

https://pharmaphorum.com/news/sarepta-forges-gene-therapy-rd-alliance-with-selecta/

Roche snaps up ex-US rights to Sarepta’s DMD gene therapy

https://pharmaphorum.com/news/roche-snaps-up-ex-us-rights-to-sareptas-dmd-gene-therapy/

Sarepta rebounds on data for limb-girdle muscular dystrophy gene therapy

https://pharmaphorum.com/news/sarepta-rebounds-on-data-for-limb-girdle-muscular-dystrophy-gene-therapy/

FDA says no to Sarepta’s golodirsen, blocking bid to expand its Duchenne stable

https://pharmaphorum.com/news/fda-says-no-to-sarepta-blocking-bid-to-expand-its-duchenne-stable/

Search